US 11583563
Adeno-associated virus formulations
granted A61KA61K31/195A61K35/76
Quick answer
US patent 11583563 (Adeno-associated virus formulations) held by Takeda Pharmaceutical Company Limited expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/195, A61K35/76, A61K47/02, A61K47/18